American Cancer Society. Cancer Facts and Figures 2010. Atlanta, GA: American Cancer Society; 2010.
Stephan, C, Cammann, H, Meyer, HA, Lein, M, Jung, K. PSA and new biomarkers within multivariate models to improve early detection of prostate cancer. Cancer Lett 2007, 249:18–29.
Wilt, TJ, Thompson, IM. Clinically localised prostate cancer. Br Med J 2006, 333:1102–1106.
Andriole, GL, Grubb, RL III, Buys, SS, Chia, D, Church, TR, Fouad, MN, Gelmann, EP, Kvale, PA, Reding, DJ, Weissfeld, JL, et al. Mortality results from a randomized prostate‐cancer screening trial. N Engl J Med 2009, 360:1310–1319.
Schröder, FH, Hugosson, J, Roobol, MJ, Tammela, TLJ, Ciatto, S, Nelen, V, Kwiatkowski, M, Lujan, M, Lilja, H, Zappa, M, et al. Screening and prostate‐cancer mortality in a randomized European study. N Engl J Med 2009, 360:1320–1328.
Fowler, JE Jr, Pandey, P, Bigler, SA, Yee, DT, Kolski, JM. Trends in diagnosis of stage T1a‐b prostate cancer. J Urol 1997, 158:1849–1852.
Stubbs, RS, Wickremesekera, SK. Selective internal radiation therapy (SIRT): a new modality for treating patients with colorectal liver metastases. HPB (Oxford) 2004, 6:133–139.
Wollner, I, Knutsen, C, Smith, P, Prieskorn, D, Chrisp, C, Andrews, J, Juni, J, Warber, S, Klevering, J, Crudup, J, et al. Effects of hepatic arterial yttrium 90 glass microspheres in dogs. Cancer 1988, 61:1336–1344.
Hilgard, P, Müller, S, Hamami, M, Sauerwein, WS, Haberkorn, U, Gerken, G, Antoch, G. Selective internal radiotherapy (radioembolization) and radiation therapy for HCC—current status and perspectives. Z Gastroenterol 2009, 47:37–54.
Buckle, T, Chin, PT, van Leeuwen, FW. (Non‐targeted) radioactive/fluorescent nanoparticles and their potential in combined pre‐ and intraoperative imaging during sentinel lymph node resection. Nanotechnology 2010, 21:482001.
Matson, JB, Grubbs, RH. Synthesis of fluorine‐18 functionalized nanoparticles for use as in vivo molecular imaging agents. J Am Chem Soc 2008, 130:6731–6733.
Phillips, WT, Goins, BA, Bao, A. Radioactive liposomes. WIREs Nanomed Nanobiotechnol 2009, 1:69–83.
Wang, SX, Bao, A, Herrera, SJ, Phillips, WT, Goins, B, Santoyo, C, Miller, FR, Otto, RA. Intraoperative 186Re‐liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model. Clin Cancer Res 2008, 14:3975–3983.
French, JT, Goins, B, Saenz, M, Li, S, Garcia‐Rojas, X, Phillips, WT, Otto, RA, Bao, A. Interventional therapy of head and neck cancer with lipid nanoparticle‐carried rhenium 186 radionuclide. J Vasc Interv Radiol 2010, 21:1271–1279.
Zavaleta, CL, Goins, BA, Bao, A, McManus, LM, McMahan, CA, Phillips, WT. Imaging of 186Re‐liposome therapy in ovarian cancer xenograft model of peritoneal carcinomatosis. J Drug Target 2008, 16:626–637.
Regulla, DF, Hieber, LB, Seidenbusch, M. Physical and biological interface dose effects in tissue due to X‐ray‐induced release of secondary radiation from metallic gold surfaces. Radiat Res 1998, 150:92–100.
Khan, MK, Minc, LD, Nigavekar, SS, Kariapper, MS, Nair, BM, Schipper, M, Cook, AC, Lesniak, WG, Balogh, LP. Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy. Nanomedicine 2008, 4:57–69.
Chanda, N, Shukla, R, Zambre, A, Mekapothula, S, Kulkarni, RR, Katti, K, Bhattacharyya, K, Fent, GM, Casteel, SW, Boote, EJ, et al. An effective strategy for the synthesis of biocompatible gold nanoparticles using cinnamon phytochemicals for phantom CT imaging and photoacoustic detection of cancerous cells. Pharm Res 2011, 28:279–291.
Chanda, N, Kattumuri, V, Shukla, R, Zambre, A, Katti, K, Upendran, A, Kulkarni, RR, Kan, P, Fent, GM, Casteel, SW, et al. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity. Proc Natl Acad Sci U S A 2010, 107:8760–8765.
Afrasiabi, Z, Shukla, R, Chanda, N, Bhaskaran, S, Upendran, A, Zambre, A, Katti, KV, Kannan, R. Nanoscale sensor design via in situ labeling of gold nanoparticles onto protein scaffolds. J Nanosci Nanotechnol 2010, 10:719–725.
Chanda, N, Shukla, R, Katti, KV, Kannan, R. Gastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nanovectors for molecular imaging. Nano Lett 2009, 9:1798–1805.
Katti, K, Chanda, N, Shukla, R, Zambre, A, Suibramanian, T, Kulkarni, RR, Kannan, R, Katti, KV. Green nanotechnology from cumin phytochemicals: generation of biocompatible gold nanoparticles. Int J Green Nanotechnol Biomed 2009, 1:B39–B52.
Katti, KK, Kattamuri, V, Bhaskaran, S, Kannan, R, Katti, KV. Facile and general method for synthesis of sugar‐coated gold nanoparticles. Int J Nanotechnol Biomed 2009, 1:B53–B59.
Nune, SK, Chanda, N, Shukla, R, Katti, K, Kulkarni, RR, Thilakavathi, S, Mekapothula, S, Kannan, R, Katti, KV. Green nanotechnology from tea: phytochemicals in tea as building blocks for production of biocompatible gold nanoparticles. J Mater Chem 2009, 19:2912–2920.
Kattumuri, VCM, Guha, S, Kannan, R, Katti, KV, Ghosh, K, Patel, RJ. Agarose‐stabilized gold nanoparticles for surface‐enhanced Raman spectroscopic detection of DNA nucleosides. Appl Phys Lett 2006, 88:153114.
Katti, KV, Kannan, R, Rahing, V, Cutler, C, Pandrapragada, R, Katti, KK, Kattumuri, V, Robertson, JD, Casteel, SJ, Jurisson, S, et al. Hybrid nanoparticles in molecular imaging and therapy. In: Czechoslovak Journal of Physics—Proceedings of the 15th Radiochemical Conference, vol 56, Supplement D, 2006.
Kannan, R, Katti, KK, Barbour, LJ, Pillarsetty, N, Barnes, CL, Katti, KV. Characterization of supramolecular (H2O)18 water morphology and water‐methanol (H2O)15(CH3OH)3 clusters in a novel phosphorus functionalized trimeric amino acid host. J Am Chem Soc 2003, 125:6955–6961.
Kannan, R, Rahing, V, Cutler, C, Pandrapragada, R, Katti, KK, Kattumuri, V, Robertson, JD, Casteel, SJ, Jurisson, S, Smith, C, et al. Nanocompatible chemistry toward fabrication of target‐specific gold nanoparticles. J Am Chem Soc 2006, 128:11342–11343.
Katti, KV, Kannan, R, Chandrasekar, M, Srinath, A, Kannan, R, Katti, K, Bhaskaran, S, Pandrapragada, RK. Optical and photophysical properties of gold nanoparticles. Mol Imaging 2004, 3:278.
Fent, GM, Casteel, SW, Kim, DY, Kannan, R, Katti, K, Chanda, N. Biodistribution of maltose and gum arabic hybrid gold nanoparticles after intravenous injection in juvenile swine. Nanomedicine 2009, 5:128–135.
Shukla, R, Nune, SK, Chanda, N, Katti, K, Mekapothula, S, Kulkarni, RR, Welshons, WV, Kannan, R, Katti, KV. Soybeans as a phytochemical reservoir for the production and stabilization of biocompatible gold nanoparticles. Small 2008, 4:1425–1436.
Katti, KV, Kannan, R, Katti, KK. Stabilized, biocompatible gold nanoparticles and enviro‐friendly method for making same. US 2009/0074674 A1 2009. US Patent pending.
Kattumuri, V, Katti, K, Bhaskaran, S, Boote, EJ, Casteel, SW, Fent, GM, Robertson, DJ, Chandrasekhar, M, Kannan, R, Katti, KV. Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X‐ray‐contrast‐imaging studies. Small 2007, 3:333–341.
Kannan, RK, Katti, KV, Katti, KK, White, HW, Cutler, CS. Methods and articles for gold nanoparticle production. US 2007/0051202 A12007. US Patent.
Katti, KV, Kannan, R, Viator, J, Chanda, N, Shukla, R, Zambre, A. Pancreatic cancer imaging and therapy using EGFR Peptide conjugated gold nanoparticles. US Patent pending October 2009.
Katti, KV. Formylation of fucntionalized P‐H bonds. A novel approach to the design of synthons for use in biomedicine. Proc Indian Acad Sci Chem Sci 1999, 111:1–12.
Chanda, N, Kan, P, Watkinson, LD, Shukla, R, Zambre, A, Carmack, TL, Engelbrecht, H, Lever, JR, Katti, K, Fent, GM, et al. Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA‐198AuNP nanoconstruct in prostate tumor‐bearing mice. Nanomedicine 2010, 6:201–209.
Boote, E, Fent, G, Kattumuri, V, Casteel, S, Katti, K, Chanda, N, Kannan, R, Katti, K, Churchill, R. Gold nanoparticle contrast in a phantom and juvenile swine: models for molecular imaging of human organs using x‐ray computed tomography. Acad Radiol 17:410–417.
Myers, WG, Colmery, BH Jr, McLellon, WM. Radioactive gold‐198 for γ radiation therapy. Am J Roentgenol Radium Ther Nucl Med 1953, 70:258–273.
Brahme, A, Svensson, H. Depth absorbed dose distributions for electrons. Phys Med Biol 1978, 23:788–792.
Attix, FH. Introduction to Radiological Physics and Radiation Dosimetry. New York: John Wiley %26 Sons; 1986.
Wang, JZ, Li, XA, Yu, CX, DiBiase, SJ. The low α/β ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us? Int J Radiat Oncol Biol Phys 2003, 57:1101–1108.
Dale, RG. The application of the linear‐quadratic dose‐effect equation to fractionated and protracted radiotherapy. Br J Radiol 1985, 58:515–528.
Khan, N, Adhami, VM, Mukhtar, H. Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr Cancer 2009, 61:836–841.
Johnson, JJ, Bailey, HH, Mukhtar, H. Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 2010, 17:3–13.
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External‐Beam Radiation Therapy. Available at: http://www.cancer.gov/clinicaltrials/search/view/print?cdrid=618542%26protocolsearchid=9255404%26version=patient.